January 17, 2022, 17:04

    Indonesia approves Merck’s COVID-19 pill for emergency use

    Indonesia approves Merck’s COVID-19 pill for emergency use

    JAKARTA, Jan 14 (Reuters) – Indonesia has approved Merck & Co Inc's (MRK.N) COVID-19 antiviral pill molnupiravir for emergency use, the country's food and drug agency said in a statement.

    A batch of 400,000 pills had arrived in Indonesia, health minister Budi Gunadi Sadikin said this week. The pill was jointly developed by U.S.-based Merck and Ridgeback Biotherapeutics.

    Register now for FREE unlimited access to Reuters.comRegisterReporting by Stanley Widianto
    Editing by Ed Davies

    Sourse: reuters.com

    Related posts

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies. You can find a detailed description in our Privacy Policy.
    Accept
    Reject
    Privacy Policy